Dennis Costa, MD
Vascular Surgery · Wausau, WINPI 1477599603
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,339 of the $5,915 with a category attached, or 73.4%. Medtronic accounts for 69.7% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $2,167, 7.2 times the $302 reported in 2019.
Across 85 payments — averaging $69.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Boston Scientific$335
- Organogenesis Inc.$311
- W. L. Gore & Associates, Inc.$285
- Endologix LLC$217
- Bard Peripheral Vascular, Inc.$149
- plus $493 from 10 others
What the payments were for
- Travel & lodging$1,57627%
- Food & beverage$4,33973%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 50 | $4,126 |
| Boston Scientific | 10 | $335 |
| Organogenesis Inc. | 4 | $311 |
| W. L. Gore & Associates, Inc. | 4 | $285 |
| Endologix LLC | 3 | $217 |
| Bard Peripheral Vascular, Inc. | 2 | $149 |
| Penumbra, Inc. | 2 | $127 |
| Stryker | 1 | $101 |
| Medical Device Business Services, Inc. | 1 | $100 |
| Reflow Medical Inc | 2 | $50 |
| AstraZeneca | 1 | $32 |
| Pfizer | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| Surmodics, Inc. | 1 | $16 |
| Cordis US CORP. | 1 | $15 |
| Cardiovascular Systems Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,915 in reported general payments places this provider in the 75th percentile of 81 vascular surgery providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 172 | $1,900 |
| Cilostazol | 83 | $1,329 |
| Gabapentin | 19 | $371 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $164 |
| Atorvastatin Calcium | 30 | $131 |
| Oxycodone Hcl | 13 | $50 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Wausau
- Stacey LejeuneWausau$105K
- Benjamin HerdrichWausau$90K
- Kevin SchoepelWausau$17K
- Daniel BrownWausau$4K
- Ralph FairchildWausau$3K
- Dai YamanouchiMadison$78K
- Tahlia WeisMarshfield$22K
- Tiziano TallaritaEau Claire$15K
- John RobertsonTomah$15K
- Momodou JammehMilwaukee$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.